✦ LIBER ✦

Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension

✍ Scribed by Archer, Stephen L.; Michelakis, Evangelos D.

Book ID: 115504909
Publisher: Massachusetts Medical Society
Year: 2009
Tongue: English
Weight: 543 KB
Volume: 361
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmct0904473

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase type 5 inhibitors in p

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

✍ David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C. 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 216 KB

Phosphodiesterase Type 5 Inhibitors for

Phosphodiesterase Type 5 Inhibitors for High-Altitude Pulmonary Hypertension

✍ Bo Jin, Xin-Ping Luo, Huan-Chun Ni, Dr Hai-Ming Shi 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 123 KB

Arterial Methemoglobin Level Predicts Th

Arterial Methemoglobin Level Predicts Therapeutic Effectiveness of Phosphodiesterase Type 5 Inhibitors in Patients with Idiopathic Pulmonary Arterial Hypertension

✍ Yuichi Tamura; Tomohiko Ono; Takashi Kawakami; Masaharu Kataoka; Motoaki Sano; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Nitric oxide pathway and phosphodiestera

Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

✍ Hossein A Ghofrani; Joanna Pepke-Zaba; Joan A Barbera; Richard Channick; Anne M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Tadalafil: A Long-Acting Phosphodiestera

Tadalafil: A Long-Acting Phosphodiesterase-5 Inhibitor for the Treatment of Pulmonary Arterial Hypertension

✍ Sally A. Arif; Henry Poon 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 380 KB

Evolving Management of Pediatric Pulmona

Evolving Management of Pediatric Pulmonary Arterial Hypertension: Impact of Phosphodiesterase Inhibitors

✍ Andrew James Wardle, Robert M. R. Tulloh 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 185 KB